These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 33330511)

  • 1. When Friendship Turns Sour: Effective Communication Between Mitochondria and Intracellular Organelles in Parkinson's Disease.
    Lin TK; Lin KJ; Lin KL; Liou CW; Chen SD; Chuang YC; Wang PW; Chuang JH; Wang TJ
    Front Cell Dev Biol; 2020; 8():607392. PubMed ID: 33330511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Overcrowded Crossroads: Mitochondria, Alpha-Synuclein, and the Endo-Lysosomal System Interaction in Parkinson's Disease.
    Lin KJ; Lin KL; Chen SD; Liou CW; Chuang YC; Lin HY; Lin TK
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial and Organellar Crosstalk in Parkinson's Disease.
    Ray B; Bhat A; Mahalakshmi AM; Tuladhar S; Bishir M; Mohan SK; Veeraraghavan VP; Chandra R; Essa MM; Chidambaram SB; Sakharkar MK
    ASN Neuro; 2021; 13():17590914211028364. PubMed ID: 34304614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson's disease.
    Calì T; Ottolini D; Brini M
    Biofactors; 2011; 37(3):228-40. PubMed ID: 21674642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk of organelles in Parkinson's disease - MiT family transcription factors as central players in signaling pathways connecting mitochondria and lysosomes.
    Lang M; Pramstaller PP; Pichler I
    Mol Neurodegener; 2022 Jul; 17(1):50. PubMed ID: 35842725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging (and converging) pathways in Parkinson's disease: keeping mitochondrial wellness.
    Cieri D; Brini M; Calì T
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1020-1030. PubMed ID: 27581196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosome Release Is Modulated by the Mitochondrial-Lysosomal Crosstalk in Parkinson's Disease Stress Conditions.
    Currim F; Singh J; Shinde A; Gohel D; Roy M; Singh K; Shukla S; Mane M; Vasiyani H; Singh R
    Mol Neurobiol; 2021 Apr; 58(4):1819-1833. PubMed ID: 33404982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoplasmic reticulum and mitochondria interplay mediates apoptotic cell death: relevance to Parkinson's disease.
    Arduíno DM; Esteves AR; Cardoso SM; Oliveira CR
    Neurochem Int; 2009 Sep; 55(5):341-8. PubMed ID: 19375464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular and Intercellular Mitochondrial Dynamics in Parkinson's Disease.
    Valdinocci D; Simões RF; Kovarova J; Cunha-Oliveira T; Neuzil J; Pountney DL
    Front Neurosci; 2019; 13():930. PubMed ID: 31619944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship of alpha-synuclein to mitochondrial dynamics and quality control.
    Thorne NJ; Tumbarello DA
    Front Mol Neurosci; 2022; 15():947191. PubMed ID: 36090250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondria and α-Synuclein: Friends or Foes in the Pathogenesis of Parkinson's Disease?
    Faustini G; Bono F; Valerio A; Pizzi M; Spano P; Bellucci A
    Genes (Basel); 2017 Dec; 8(12):. PubMed ID: 29292725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current perspective of mitochondrial biology in Parkinson's disease.
    Ammal Kaidery N; Thomas B
    Neurochem Int; 2018 Jul; 117():91-113. PubMed ID: 29550604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial dysfunction in Parkinson's disease.
    Hu Q; Wang G
    Transl Neurodegener; 2016; 5():14. PubMed ID: 27453777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic Dysfunction in Parkinson's Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism.
    Anandhan A; Jacome MS; Lei S; Hernandez-Franco P; Pappa A; Panayiotidis MI; Powers R; Franco R
    Brain Res Bull; 2017 Jul; 133():12-30. PubMed ID: 28341600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rescue of microtubule-dependent traffic recovers mitochondrial function in Parkinson's disease.
    Esteves AR; Gozes I; Cardoso SM
    Biochim Biophys Acta; 2014 Jan; 1842(1):7-21. PubMed ID: 24120997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
    Büeler H
    Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease.
    Grassi D; Howard S; Zhou M; Diaz-Perez N; Urban NT; Guerrero-Given D; Kamasawa N; Volpicelli-Daley LA; LoGrasso P; Lasmézas CI
    Proc Natl Acad Sci U S A; 2018 Mar; 115(11):E2634-E2643. PubMed ID: 29487216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VPS35 in Dopamine Neurons Is Required for Endosome-to-Golgi Retrieval of Lamp2a, a Receptor of Chaperone-Mediated Autophagy That Is Critical for α-Synuclein Degradation and Prevention of Pathogenesis of Parkinson's Disease.
    Tang FL; Erion JR; Tian Y; Liu W; Yin DM; Ye J; Tang B; Mei L; Xiong WC
    J Neurosci; 2015 Jul; 35(29):10613-28. PubMed ID: 26203154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATP13A2 protects dopaminergic neurons in Parkinson's disease: from biology to pathology.
    Dang T; Cao WJ; Zhao R; Lu M; Hu G; Qiao C
    J Biomed Res; 2022 Mar; 36(2):98-108. PubMed ID: 35387901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.